CIK 1778253
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 80.72% | 99 |
| Unclassified | 18.16% | 19 |
| Health Care Equipment & Supplies | 1.09% | 6 |
| Banks | 0.02% | 1 |
| Health Care Providers & Services | 0.01% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | Unclassified | 10.98% | |
| 2 | KOD | Kodiak Sciences Inc. | Health Care | 6.90% |
| 3 | ALMS | ALUMIS INC. | Health Care | 3.82% |
| 4 | PCVX | Vaxcyte, Inc. | Health Care | 3.56% |
| 5 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 3.30% |
| 6 | HROW | HARROW, INC. | Health Care | 2.74% |
| 7 | RLMD | RELMADA THERAPEUTICS, INC. | Health Care | 2.68% |
| 8 | CYTK | CYTOKINETICS INC | Health Care | 2.67% |
| 9 | TENX | TENAX THERAPEUTICS, INC. | Health Care | 2.33% |
| 10 | CAPR | CAPRICOR THERAPEUTICS, INC. | Health Care | 2.30% |
108/127 names classified · sector 81.8% of weight · industry 81.8% · mkt cap 77.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 81.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 3% of book weight classified — the grid is NOT representative of the whole book.
Classified: 3.3% of book weight (6/121 names) · unclassified 96.7%: , KOD, ALMS, PCVX, PRAX, HROW, RLMD, CYTK, TENX, CAPR +105 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | 1,456,378 | $77M | 11.0% | TRIM −9% |
| 2 | KODKODIAK SCIENCES INC | 1,265,795 | $48M | 6.9% | ADD 76% |
| 3 | ALMSALUMIS INC | 1,213,548 | $27M | 3.8% | NEW |
| 4 | PCVXVAXCYTE INC | 428,682 | $25M | 3.6% | ADD 13% |
| 5 | PRAXPRAXIS PRECISION MEDICINES I | 71,581 | $23M | 3.3% | TRIM −17% |
| 6 | HROWHARROW INC | 543,047 | $19M | 2.7% | ADD 196% |
| 7 | RLMDRELMADA THERAPEUTICS INC | 2,688,359 | $19M | 2.7% | TRIM −12% |
| 8 | CYTKCYTOKINETICS INC | 283,572 | $19M | 2.7% | ADD 64% |
| 9 | TENXTENAX THERAPEUTICS INC | 1,017,600 | $16M | 2.3% | ADD 5% |
| 10 | CAPRCAPRICOR THERAPEUTICS INC | 528,015 | $16M | 2.3% | TRIM −9% |
| 11 | RVMDREVOLUTION MEDICINES INC | 163,142 | $16M | 2.3% | ADD 18% |
| 12 | CLDXCELLDEX THERAPEUTICS INC NEW | 461,247 | $15M | 2.1% | NEW |
| 13 | PHVSPHARVARIS N V | 486,856 | $14M | 2.0% | HOLD |
| 14 | CNTBCONNECT BIOPHARMA HLDGS LTD | 5,388,486 | $13M | 1.9% | ADD 13% |
| 15 | DRUGBRIGHT MINDS BIOSCIENCES INC | 166,647 | $12M | 1.7% | ADD 5% |
| 16 | BBIOBRIDGEBIO PHARMA INC | 160,120 | $12M | 1.7% | NEW |
| 17 | ORKAORUKA THERAPEUTICS INC | 242,021 | $12M | 1.7% | NEW |
| 18 | ANROALTO NEUROSCIENCE INC | 515,000 | $12M | 1.7% | HOLD |
| 19 | SOLENO THERAPEUTICS INC | 344,123 | $12M | 1.6% | ADD 400% |
| 20 | MAZEMAZE THERAPEUTICS INC | 378,999 | $11M | 1.6% | TRIM −41% |
| 21 | ANIPANI PHARMACEUTICALS INC | 147,085 | $11M | 1.6% | NEW |
| 22 | CTNMCONTINEUM THERAPEUTICS INC | 807,874 | $11M | 1.5% | ADD 186% |
| 23 | RAREULTRAGENYX PHARMACEUTICAL IN | 482,571 | $10M | 1.4% | ADD 3708% |
| 24 | IONSIONIS PHARMACEUTICALS INC | 127,038 | $10M | 1.4% | TRIM −37% |
| 25 | OLMAOLEMA PHARMACEUTICALS INC | 598,281 | $9M | 1.3% | TRIM −21% |
| 26 | EPRXEupraxia Pharmaceuticals Inc | 1,214,741 | $9M | 1.3% | ADD 99% |
| 27 | DMRADAMORA THERAPEUTICS INC | 335,710 | $9M | 1.2% | ADD 18% |
| 28 | PVLAPALVELLA THERAPEUTICS INC | 64,626 | $8M | 1.2% | NEW |
| 29 | FULCFULCRUM THERAPEUTICS INC | 1,049,161 | $8M | 1.2% | TRIM −24% |
| 30 | VERAVERA THERAPEUTICS INC | 200,000 | $8M | 1.2% | NEW |
| 31 | SPRBSPRUCE BIOSCIENCES INC | 121,356 | $8M | 1.1% | HOLD |
| 32 | IVAINVENTIVA SA | 1,429,101 | $8M | 1.1% | ADD 184% |
| 33 | JBIOJADE BIOSCIENCES INC | 512,349 | $7M | 1.0% | ADD 71% |
| 34 | OCGNOCUGEN INC | 3,962,972 | $7M | 1.0% | NEW |
| 35 | ZURAZURA BIO LTD | 1,193,492 | $7M | 1.0% | ADD 49% |
| 36 | OVIDOVID THERAPEUTICS INC | 2,894,704 | $6M | 0.9% | ADD 1069% |
| 37 | ABVXABIVAX SA | 57,635 | $6M | 0.9% | TRIM −72% |
| 38 | LLYELI LILLY & CO | 6,547 | $6M | 0.9% | TRIM −53% |
| 39 | ACOGALPHA COGNITION INC | 1,056,259 | $6M | 0.8% | HOLD |
| 40 | PTHSPELTHOS THERAPEUTICS INC | 256,598 | $5M | 0.8% | HOLD |
| 41 | SRZNSURROZEN INC | 173,107 | $5M | 0.7% | ADD 163% |
| 42 | TECXTECTONIC THERAPEUTIC INC | 157,537 | $5M | 0.7% | NEW |
| 43 | ALECALECTOR INC | 2,082,606 | $4M | 0.6% | HOLD |
| 44 | LEGNLEGEND BIOTECH CORP | 226,888 | $4M | 0.6% | HOLD |
| 45 | KPTIKARYOPHARM THERAPEUTICS INC | 733,435 | $4M | 0.6% | ADD 35% |
| 46 | LPCNLIPOCINE INC NEW | 508,556 | $4M | 0.6% | ADD 155% |
| 47 | DCTHDELCATH SYS INC | 431,251 | $4M | 0.6% | HOLD |
| 48 | ARVNARVINAS INC | 358,257 | $4M | 0.5% | HOLD |
| 49 | CMPSCOMPASS PATHWAYS PLC | 675,000 | $4M | 0.5% | ADD 69% |
| 50 | CRDLCARDIOL THERAPEUTICS INC | 2,725,000 | $4M | 0.5% | NEW |
| 51 | BHVNBIOHAVEN LTD | 412,481 | $3M | 0.5% | ADD 94% |
| 52 | IVVDINVIVYD INC | 2,656,570 | $3M | 0.5% | HOLD |
| 53 | ANNXANNEXON INC | 580,244 | $3M | 0.5% | ADD 152% |
| 54 | FBRXFORTE BIOSCIENCES INC | 118,972 | $3M | 0.4% | TRIM −60% |
| 55 | LXEOLEXEO THERAPEUTICS INC | 513,011 | $3M | 0.4% | HOLD |
| 56 | PCSCPERCEPTIVE CAP SOLUTIONS COR | 240,951 | $3M | 0.4% | HOLD |
| 57 | VIRVIR BIOTECHNOLOGY INC | 293,258 | $3M | 0.4% | TRIM −49% |
| 58 | NXTCNEXTCURE INC | 238,303 | $3M | 0.4% | HOLD |
| 59 | NMRANEUMORA THERAPEUTICS INC. | 1,278,408 | $2M | 0.4% | HOLD |
| 60 | ABOSACUMEN PHARMACEUTICALS INC | 1,053,797 | $2M | 0.4% | ADD 314% |
| 61 | CABACABALETTA BIO INC | 900,000 | $2M | 0.3% | HOLD |
| 62 | BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | 270,231 | $2M | 0.3% | ADD 23% |
| 63 | PRQRPROQR THRAPEUTICS N V | 1,492,229 | $2M | 0.3% | HOLD |
| 64 | NUVLNUVALENT INC | 23,594 | $2M | 0.3% | TRIM −60% |
| 65 | JAZZJAZZ PHARMACEUTICALS PLC | 12,460 | $2M | 0.3% | TRIM −92% |
| 66 | DBVTDBV TECHNOLOGIES S A | 525,000 | $2M | 0.3% | HOLD |
| 67 | TARSTARSUS PHARMACEUTICALS INC | 31,166 | $2M | 0.3% | HOLD |
| 68 | KLRSKALARIS THERAPEUTICS INC | 360,000 | $2M | 0.3% | HOLD |
| 69 | AVRANTERIS TECHNOLOGIES GLOBAL | 366,571 | $2M | 0.3% | NEW |
| 70 | SLDBSOLID BIOSCIENCES INC | 264,409 | $2M | 0.3% | ADD 65% |
| 71 | IBIOIBIO INC | 957,062 | $2M | 0.3% | HOLD |
| 72 | CPIXCUMBERLAND PHARMACEUTICALS I | 553,153 | $2M | 0.3% | HOLD |
| 73 | SLNSILENCE THERAPEUTICS PLC | 865,784 | $2M | 0.2% | HOLD |
| 74 | LABDDIREXION SHS ETF TR | 105,822 | $2M | 0.2% | ADD 159% |
| 75 | QUREUNIQURE NV | 91,060 | $1M | 0.2% | HOLD |
| 76 | QNRXQUOIN PHARMACEUTICALS LTD | 211,538 | $1M | 0.2% | HOLD |
| 77 | TRAWTRAWS PHARMA INC | 678,142 | $1M | 0.2% | HOLD |
| 78 | DERMJOURNEY MED CORP | 251,436 | $1M | 0.2% | HOLD |
| 79 | VSTMVERASTEM INC | 213,865 | $1M | 0.2% | HOLD |
| 80 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 58,803 | $1M | 0.2% | NEW |
| 81 | STIMNEURONETICS INC | 701,182 | $1M | 0.1% | HOLD |
| 82 | LYELLYELL IMMUNOPHARMA INC | 41,081 | $824,084 | 0.1% | HOLD |
| 83 | PEPGPEPGEN INC | 447,165 | $791,482 | 0.1% | HOLD |
| 84 | KEZAR LIFE SCIENCES INC | 102,211 | $758,405 | 0.1% | HOLD |
| 85 | IMUXIMMUNIC INC | 674,662 | $748,876 | 0.1% | HOLD |
| 86 | CENTESSA PHARMACEUTICALS PLC | 18,113 | $719,448 | 0.1% | NEW |
| 87 | KALVISTA PHARMACEUTICALS INC | 35,119 | $706,946 | 0.1% | HOLD |
| 88 | PMNPROMIS NEUROSCIENCES INC | 55,000 | $698,500 | 0.1% | NEW |
| 89 | INSMINSMED INC | 4,214 | $689,074 | 0.1% | TRIM −55% |
| 90 | HELPCYBIN INC | 132,153 | $634,334 | 0.1% | HOLD |
| 91 | ACADACADIA PHARM | 28,099 | $625,484 | 0.1% | NEW |
| 92 | WVEWAVE LIFE SCIENCES LTD | 85,285 | $618,317 | 0.1% | HOLD |
| 93 | EQEQUILLIUM INC | 303,555 | $607,110 | 0.1% | HOLD |
| 94 | PASGPASSAGE BIO INC | 68,124 | $534,773 | 0.1% | NEW |
| 95 | GUTSFRACTYL HEALTH INC | 1,100,000 | $503,580 | 0.1% | HOLD |
| 96 | PALIPALISADE BIO INC | 274,978 | $481,212 | 0.1% | HOLD |
| 97 | IMTXIMMATICS N.V | 48,569 | $477,919 | 0.1% | HOLD |
| 98 | VKTXVIKING THERAPEUTICS INC | 9,717 | $316,191 | 0.0% | HOLD |
| 99 | SGMOQSANGAMO THERAPEUTICS INC | 1,218,671 | $300,890 | 0.0% | HOLD |
| 100 | VTGNVISTAGEN THERAPEUTICS INC | 519,077 | $296,654 | 0.0% | HOLD |
| 101 | VERUVERU INC | 133,517 | $295,073 | 0.0% | HOLD |
| 102 | EVAXEVAXION AS SPONSORED ADS | 74,698 | $277,876 | 0.0% | HOLD |
| 103 | LXRXLEXICON PHARMACEUTICALS INC | 164,674 | $256,892 | 0.0% | HOLD |
| 104 | ANLADLAI NORTYE LTD | 33,899 | $234,581 | 0.0% | NEW |
| 105 | MGNXMACROGENICS INC | 74,893 | $216,441 | 0.0% | HOLD |
| 106 | VYGRVOYAGER THERAPEUTICS INC | 53,063 | $204,823 | 0.0% | HOLD |
| 107 | FTHSENSEI BIOTHERAPEUTICS INC | 6,351 | $200,184 | 0.0% | TRIM −70% |
| 108 | NEUPNEUPHORIA THERAPEUTICS INC | 47,443 | $193,093 | 0.0% | HOLD |
| 109 | VYNEVYNE THERAPEUTICS INC | 264,912 | $158,284 | 0.0% | HOLD |
| 110 | PURRHYPERLIQUID STRATEGIES INC | 30,001 | $152,705 | 0.0% | HOLD |
| 111 | NYXHNYXOAH S A | 47,358 | $138,285 | 0.0% | HOLD |
| 112 | RNACCARTESIAN THERAPEUTICS INC | 20,807 | $127,963 | 0.0% | HOLD |
| 113 | PMVPPMV PHARMACEUTICALS INC | 89,136 | $110,529 | 0.0% | HOLD |
| 114 | CNSPCNS PHARMACEUTICALS INC | 45,830 | $109,992 | 0.0% | HOLD |
| 115 | CMPXCOMPASS THERAPEUTICS INC | 18,000 | $95,220 | 0.0% | TRIM −98% |
| 116 | IOBTQIO BIOTECH INC | 1,386,565 | $81,391 | 0.0% | HOLD |
| 117 | CMMBCHEMOMAB THERAPEUTICS LTD | 51,793 | $81,315 | 0.0% | HOLD |
| 118 | PHGEBIOMX INC | 19,473 | $73,102 | 0.0% | HOLD |
| 119 | RZLTREZOLUTE INC | 16,479 | $50,261 | 0.0% | HOLD |
| 120 | MGRXMANGOCEUTICALS INC | 138,146 | $49,747 | 0.0% | HOLD |
| 121 | SHUTTLE PHARMACTCLS HLDGS IN | 68,993 | $46,832 | 0.0% | HOLD |
| 122 | AIRSAIRSCULPT TECHNOLOGIES INC | 16,398 | $46,405 | 0.0% | HOLD |
| 123 | AEMDAETHLON MED INC | 14,364 | $31,458 | 0.0% | HOLD |
| 124 | GCTKGLUCOTRACK INC | 45,830 | $29,790 | 0.0% | HOLD |
| 125 | TOVXTHERIVA BIOLOGICS INC | 112,076 | $21,944 | 0.0% | HOLD |
| 126 | JSPRJASPER THERAPEUTICS INC | 24,093 | $21,110 | 0.0% | HOLD |
| 127 | AUTONOMIX MED INC | 18,688 | $7,290 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC | 308K | 308K | 58K | 164K | 1.6M | 1.5M | $77M |
| KODKODIAK SCIENCES INC | 576K | 650K | 600K | 414K | 720K | 1.3M | $48M |
| ALMSALUMIS INC | — | — | — | — | — | 1.2M | $27M |
| PCVXVAXCYTE INC | — | 200K | 305K | 312K | 379K | 429K | $25M |
| PRAXPRAXIS PRECISION MEDICINES I | — | 146K | 277K | 29K | 87K | 72K | $23M |
| HROWHARROW INC | — | — | — | — | 183K | 543K | $19M |
| RLMDRELMADA THERAPEUTICS INC | 40K | 40K | 40K | 1.8M | 3.1M | 2.7M | $19M |
| CYTKCYTOKINETICS INC | 150K | 150K | 233K | 223K | 173K | 284K | $19M |
| TENXTENAX THERAPEUTICS INC | — | — | — | 968K | 968K | 1.0M | $16M |
| CAPRCAPRICOR THERAPEUTICS INC | — | — | — | 265K | 578K | 528K | $16M |
| RVMDREVOLUTION MEDICINES INC | — | — | — | — | 138K | 163K | $16M |
| CLDXCELLDEX THERAPEUTICS INC NEW | — | — | — | — | — | 461K | $15M |
| PHVSPHARVARIS N V | — | — | — | 210K | 487K | 487K | $14M |
| CNTBCONNECT BIOPHARMA HLDGS LTD | — | — | — | — | 4.8M | 5.4M | $13M |
| DRUGBRIGHT MINDS BIOSCIENCES INC | 152K | 65K | 65K | 15K | 159K | 167K | $12M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
